260 related articles for article (PubMed ID: 31356494)
1. SEVERITY OF DIABETIC MACULAR EDEMA CORRELATES WITH RETINAL VASCULAR BED AREA ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: DAVE Study.
Fan W; Uji A; Wang K; Falavarjani KG; Wykoff CC; Brown DM; Van Hemert J; Sagong M; Sadda SR; Ip M
Retina; 2020 Jun; 40(6):1029-1037. PubMed ID: 31356494
[TBL] [Abstract][Full Text] [Related]
2. Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.
Fan W; Wang K; Ghasemi Falavarjani K; Sagong M; Uji A; Ip M; Wykoff CC; Brown DM; van Hemert J; Sadda SR
Am J Ophthalmol; 2017 Aug; 180():110-116. PubMed ID: 28579062
[TBL] [Abstract][Full Text] [Related]
3. Baseline retinal vascular bed area on ultra-wide field fluorescein angiography correlates with the anatomical outcome of diabetic macular oedema to ranibizumab therapy: two-year analysis of the DAVE Study.
Fan W; Uji A; Wykoff CC; Brown DM; van Hemert J; Falavarjani KG; Wang K; Sadda SR; Ip M
Eye (Lond); 2023 Mar; 37(4):678-683. PubMed ID: 35332289
[TBL] [Abstract][Full Text] [Related]
4. Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in Patients with Diabetic Macular Edema.
Fang M; Fan W; Shi Y; Ip MS; Wykoff CC; Wang K; Falavarjani KG; Brown DM; van Hemert J; Sadda SR
Am J Ophthalmol; 2019 Oct; 206():74-81. PubMed ID: 30959003
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography.
Fan W; Nittala MG; Fleming A; Robertson G; Uji A; Wykoff CC; Brown DM; van Hemert J; Ip M; Wang K; Falavarjani KG; Singer M; Sagong M; Sadda SR
Am J Ophthalmol; 2020 Jan; 209():99-106. PubMed ID: 31472160
[TBL] [Abstract][Full Text] [Related]
6. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema.
Cheong KX; Lee SY; Ang M; Teo KYC
Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934
[TBL] [Abstract][Full Text] [Related]
7. NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY Study.
Fan W; Nittala MG; Wykoff CC; Brown DM; Uji A; Hemert JV; Fleming A; Robertson G; Sadda SR; Ip M
Retina; 2022 Mar; 42(3):426-433. PubMed ID: 34803132
[TBL] [Abstract][Full Text] [Related]
8. Retinal vascular bed area on ultra-wide field fluorescein angiography indicates the severity of diabetic retinopathy.
Fan W; Uji A; Nittala M; Wykoff CC; Brown D; Fleming A; Robertson G; van Hemert J; Sadda S; Ip MS
Br J Ophthalmol; 2022 Aug; 106(8):1126-1131. PubMed ID: 33827861
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
Reddy RK; Pieramici DJ; Gune S; Ghanekar A; Lu N; Quezada-Ruiz C; Baumal CR
Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001
[TBL] [Abstract][Full Text] [Related]
10. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.
Figueiredo N; Srivastava SK; Singh RP; Babiuch A; Sharma S; Rachitskaya A; Talcott K; Reese J; Hu M; Ehlers JP
Ophthalmol Retina; 2020 Feb; 4(2):154-163. PubMed ID: 31757691
[TBL] [Abstract][Full Text] [Related]
12. RETINAL VASCULAR BED AREA IN EYES WITH RETINAL VEIN OCCLUSION ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY: WAVE Study.
Fan W; Fleming A; Hemert JV; Wykoff CC; Brown DM; Robertson G; Wang K; Falavarjani KG; Sadda SR; Ip M
Retina; 2022 Oct; 42(10):1883-1888. PubMed ID: 35976232
[TBL] [Abstract][Full Text] [Related]
13. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
14. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
[TBL] [Abstract][Full Text] [Related]
15. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
[TBL] [Abstract][Full Text] [Related]
16. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
[TBL] [Abstract][Full Text] [Related]
17. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
18. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC;
Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept.
Blindbæk SL; Peto T; Grauslund J
Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608
[TBL] [Abstract][Full Text] [Related]
20. Foveal Microvascular Integrity Association With Anti-VEGF Treatment Response for Diabetic Macular Edema.
Huang WH; Lai CC; Chuang LH; Huang JC; Wu CH; Lin YT; Yeung L
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):41. PubMed ID: 34323921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
